Travere Therapeutics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$105.2M
80 notices · 2,098,338 sh
Oct 2025 to Oct 2026
Reported ·
$37.2M
75 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
68 of 75 reported sales carry the 10b5-1 box. Together they are 1.10% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-17ERIC DUBE, CHIEF EXECUTIVE OFFICER$6,887,136
2026-09-17PETER HEERMA, CHIEF COMMERCIAL OFFICER$525,741
2026-09-16WILLIAM ROTE, Chief Research Officer$7,054,254
2026-09-16PETER HEERMA, CHIEF COMMERCIAL OFFICER$10.8M
2026-09-16ERIC DUBE, CHIEF EXECUTIVE OFFICER$12.2M
2026-09-15SANDRA CALVIN, SVP, CHIEF ACCOUNTING OFFICER$353,621
2026-09-15CHRISTOPHER CLINE, CHIEF FINANCIAL OFFICER$3,322,921
2026-09-15ELIZABETH REED, Chief Legal Officer and GC$2,603,705
2026-09-15ERIC DUBE, CHIEF EXECUTIVE OFFICER$6,293,866
2026-09-15PETER HEERMA, CHIEF COMMERCIAL OFFICER$6,723,080
2026-09-15WILLIAM ROTE, Chief Research Officer$6,328,866
2026-09-15JULA INRIG, CHIEF MEDICAL OFFICER$2,939,102
2026-09-10JEFFREY MECKLER, Director$1,324,400
2026-08-18GARY LYONS, Director$317,650
2026-08-17GARY A LYONS, Director$310,700
2026-06-12ROY BAYNES, Director$225,000
Form 4, 2026-06-16: sold 4,500 at $50.00 Form 4 ↗
2026-06-12Coughlin Timothy, Director$500,430
Form 4, 2026-06-16: sold 10,000 at $50.07 Form 4 ↗
2026-05-15Coughlin Timothy, Director$141,183
Form 4, 2026-05-19: sold 3,250 at $43.49 Form 4 ↗
2026-05-06Dube Eric M, CHIEF EXECUTIVE OFFICER$988,875
Form 4, 2026-05-06: sold 22,500 at $43.95 Form 4 ↗
2026-05-06ROTE WILLIAM E., Chief Research Officer$121,434
Form 4, 2026-05-06: sold 2,763 at $43.95 Form 4 ↗
2026-05-06CHRISTOPHER CLINE, CHIEF FINANCIAL OFFICER$13,625
2026-05-06ELIZABETH REED, Chief Legal Officer and GC$91,240
2026-05-06JULA INRIG, CHIEF MEDICAL OFFICER$13,668
2026-05-05ROY BAYNES, Director$209,925
Form 4, 2026-05-06: sold 4,500 at $46.65 Form 4 ↗
2026-05-05Christopher Cline, CHIEF FINANCIAL OFFICER$101,744
Form 4, 2026-05-06: sold 2,491 at $46.31 Form 4 ↗
2026-05-05Elizabeth E. Reed, Chief Legal Officer and GC$101,417
2026-05-05Jula Inrig, CHIEF MEDICAL OFFICER$101,417
2026-05-05Peter Heerma, CHIEF COMMERCIAL OFFICER$101,417
Form 4, 2026-05-06: sold 2,174 at $46.65 Form 4 ↗
2026-05-04ELIZABETH REED, Chief Legal Officer and GC$900,000
Form 4, 2026-05-06: sold 24,250 at $45.06 Form 4 ↗
2026-05-04JEFFREY MECKLER, Director$360,000
Form 4, 2026-05-06: sold 8,000 at $45.00 Form 4 ↗
2026-05-04JULA INRIG, CHIEF MEDICAL OFFICER$900,000
Form 4, 2026-05-06: sold 22,485 at $45.15 Form 4 ↗
2026-05-01ROY BAYNES, Director$431,145
Form 4, 2026-05-04: sold 9,750 at $44.22 Form 4 ↗
2026-04-22ROTE WILLIAM E., Chief Research Officer$355,719
Form 4, 2026-04-23: sold 9,100 at $39.09 Form 4 ↗
2026-04-15Dube Eric M, CHIEF EXECUTIVE OFFICER$2,629,833
Form 4, 2026-04-15: sold 64,000 at $41.09 Form 4 ↗
2026-04-15ELIZABETH REED, Chief Legal Officer and GC$283,823
2026-04-15CHRISTOPHER CLINE, CHIEF FINANCIAL OFFICER$43,207
2026-04-15JULA INRIG, CHIEF MEDICAL OFFICER$43,377
2026-04-14GARY A LYONS, Officer$245,600
Form 4, 2026-04-16: sold 8,000 at $41.07 Form 4 ↗
2026-04-14CHRISTOPHER CLINE, CHIEF FINANCIAL OFFICER$370
2026-04-14ELIZABETH REED, Chief Legal Officer and GC$1,540,125
Form 4, 2026-04-15: sold 51,500 at $41.29 Form 4 ↗
2026-04-14ROY BAYNES, Director$1,352,130
Form 4, 2026-04-16: sold 32,750 at $41.29 Form 4 ↗
2026-04-14SANDRA CALVIN, SVP, CHIEF ACCOUNTING OFFICER$902,595
Form 4, 2026-04-16: sold 21,977 at $41.07 Form 4 ↗
2026-04-14Elizabeth E. Reed, Chief Legal Officer and GC$302,516
2026-04-14Jula Inrig, CHIEF MEDICAL OFFICER$302,516
Form 4, 2026-04-15: sold 8,233 at $42.01 Form 4 ↗
2026-04-14Peter Heerma, CHIEF COMMERCIAL OFFICER$302,516
Form 4, 2026-04-15: sold 7,215 at $41.93 Form 4 ↗
2026-04-14Christopher Cline, CHIEF FINANCIAL OFFICER$303,522
2026-04-13Christopher Cline, CHIEF FINANCIAL OFFICER$1,875
Form 4, 2026-04-15: sold 8,327 at $41.91 Form 4 ↗
2026-04-06ROY BAYNES, Director$330,000
Form 4, 2026-04-07: sold 10,000 at $33.00 Form 4 ↗
2026-04-01Dube Eric M, CHIEF EXECUTIVE OFFICER$1,855,655
Form 4, 2026-04-02: sold 60,000 at $30.93 Form 4 ↗
2026-04-01ELIZABETH REED, Chief Legal Officer and GC$300,000
Form 4, 2026-04-02: sold 10,000 at $30.00 Form 4 ↗
2026-03-16ELIZABETH REED, Chief Legal Officer and GC$280,861
Form 4, 2026-03-18: sold 10,000 at $28.09 Form 4 ↗
2026-02-20Dube Eric M, CHIEF EXECUTIVE OFFICER$1,805,766
Form 4, 2026-02-24: sold 60,000 at $30.10 Form 4 ↗
2026-02-17ELIZABETH REED, Chief Legal Officer and GC$278,317
Form 4, 2026-02-19: sold 10,000 at $27.83 Form 4 ↗
2026-02-04ELIZABETH REED, Chief Legal Officer and GC$96,360
Form 4, 2026-02-05: sold 2,994 at $32.18 Form 4 ↗
2026-02-04JULA INRIG, CHIEF MEDICAL OFFICER$57,299
Form 4, 2026-02-05: sold 1,779 at $32.21 Form 4 ↗
2026-02-04CHRISTOPHER CLINE, CHIEF FINANCIAL OFFICER$56,166
Form 4, 2026-02-05: sold 1,745 at $32.19 Form 4 ↗
2026-02-03Peter Heerma, CHIEF COMMERCIAL OFFICER$234,799
Form 4, 2026-02-03: sold 7,310 at $32.12 Form 4 ↗
2026-02-03Dube Eric M, CHIEF EXECUTIVE OFFICER$3,289,860
Form 4, 2026-02-03: sold 100,087 at $32.28 Form 4 ↗
2026-02-03ROTE WILLIAM E., Chief Research Officer$409,100
Form 4, 2026-02-03: sold 12,446 at $32.87 Form 4 ↗
2026-02-03Elizabeth E. Reed, Chief Legal Officer and GC$230,464
Form 4, 2026-02-03: sold 7,175 at $32.12 Form 4 ↗
2026-02-03Sandra Calvin, SVP, CHIEF ACCOUNTING OFFICER$139,177
Form 4, 2026-02-03: sold 4,333 at $32.12 Form 4 ↗
2026-02-03Christopher Cline, CHIEF FINANCIAL OFFICER$232,616
Form 4, 2026-02-03: sold 7,242 at $32.12 Form 4 ↗
2026-02-03Jula Inrig, CHIEF MEDICAL OFFICER$223,429
Form 4, 2026-02-03: sold 6,956 at $32.12 Form 4 ↗
2026-01-27Dube Eric M, CHIEF EXECUTIVE OFFICER$1,560,983
2026-01-23Dube Eric M, CHIEF EXECUTIVE OFFICER$244,153
Form 4, 2026-01-27: sold 60,000 at $30.09 Form 4 ↗
2026-01-20ELIZABETH REED, Chief Legal Officer and GC$273,420
Form 4, 2026-01-21: sold 10,000 at $27.34 Form 4 ↗
2026-01-06JULA INRIG, CHIEF MEDICAL OFFICER$16,799
2026-01-05Jula Inrig, CHIEF MEDICAL OFFICER$81,606
Form 4, 2026-01-07: sold 2,476 at $39.74 Form 4 ↗
2025-12-24Heerma Peter, CHIEF COMMERCIAL OFFICER$199,200
Form 4, 2025-12-29: sold 4,980 at $40.00 Form 4 ↗
2025-12-24ROTE WILLIAM E., Chief Research Officer$2,406,179
Form 4, 2025-12-29: sold 60,000 at $40.10 Form 4 ↗
2025-12-24JULA INRIG, CHIEF MEDICAL OFFICER$630,005
Form 4, 2025-12-29: sold 15,000 at $42.00 Form 4 ↗
2025-12-24SANDRA CALVIN, SVP, CHIEF ACCOUNTING OFFICER$296,080
Form 4, 2025-12-29: sold 7,402 at $40.00 Form 4 ↗
2025-12-15SANDRA CALVIN, SVP, CHIEF ACCOUNTING OFFICER$104,760
Form 4, 2025-12-16: sold 2,910 at $36.00 Form 4 ↗
2025-12-01CHRISTOPHER CLINE, CHIEF FINANCIAL OFFICER$700,200
Form 4, 2025-12-03: sold 20,000 at $35.01 Form 4 ↗
2025-11-04SANDRA CALVIN, SVP, CHIEF ACCOUNTING OFFICER$2,416,140
Form 4, 2025-11-06: sold 67,115 at $36.00 Form 4 ↗
2025-10-31Heerma Peter, CHIEF COMMERCIAL OFFICER$195,685
Form 4, 2025-11-04: sold 5,591 at $35.00 Form 4 ↗
2025-10-31Coughlin Timothy, Director$629,693
Form 4, 2025-11-04: sold 18,000 at $35.03 Form 4 ↗
2025-10-29Dube Eric M, CHIEF EXECUTIVE OFFICER$817,045
2025-10-28Dube Eric M, CHIEF EXECUTIVE OFFICER$2,821,217
Form 4, 2025-10-30: sold 120,000 at $30.32 Form 4 ↗